Arrevus Competitors and Similar CompaniesClear all
Arrevus's competitors and similar companies include NKGen Biotech and Speratum.
 NKGen Biotech NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells. |  Speratum Speratum is a biotechnology company developing targeted molecular therapies for the treatment of cancer. | ||
Founding Date | Founding Date 2017 | Founding Date 2017 | Founding Date 2014 |
Type | Type Subsidiary | Type Public | Type Private |
Tags | |||
Locations | Locations HQ | Locations Santa Ana, US HQ | Locations HQ |
Employees | Employees 3 | Employees 7316% increase | Employees 9 |
Funding | |||
Total funding raised | Total funding raised $ 1m | Total funding raised $ 11m | Total funding raised $ 2.8m |
For sources of this data, please see the company profile
View Company Profiles
NKGen Biotech
HQ
Santa Ana, US
Employees
73↑ 16% increase
NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells.
View companySperatum
HQ
Employees
9
Speratum is a biotechnology company developing targeted molecular therapies for the treatment of cancer.
View company